Answers are grounded in this paper and cite their sources.
ISSUE: A paradigm shift is afoot in which the "last shall be first," namely, use of long-acting injectable (LAI) antipsychotics, rather than being reserved for use only at the last stages of schizophrenia, may be shifting to first-line treatment of early episodes of this illness.
No takes yet. Share an insight, caveat, or question.
Stephen M. Stahl (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: